International Biotechnology (LON:IBT – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of GBX 1,044.88 and traded as high as GBX 1,050. International Biotechnology shares last traded at GBX 1,050, with a volume of 63,625 shares trading hands.
International Biotechnology Trading Down 1.4%
The firm has a 50-day moving average of GBX 1,091.38 and a two-hundred day moving average of GBX 1,045.62. The firm has a market capitalization of £324.44 million, a P/E ratio of 4.24 and a beta of 0.46. The company has a current ratio of 0.11, a quick ratio of 0.32 and a debt-to-equity ratio of 9.43.
International Biotechnology Company Profile
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.
See Also
- Five stocks we like better than International Biotechnology
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
